These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1688295)

  • 41. Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
    James CW; McNelis KC; Szabo S
    Am J Health Syst Pharm; 2003 Aug; 60(15):1572-4. PubMed ID: 12951757
    [No Abstract]   [Full Text] [Related]  

  • 42. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
    Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
    Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
    Morris-Jones SD; Easterbrook PJ
    J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481
    [No Abstract]   [Full Text] [Related]  

  • 44. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
    Beumont MG; Graziani A; Ubel PA; MacGregor RR
    Am J Med; 1996 Jun; 100(6):611-6. PubMed ID: 8678080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Zakrzewska M; Roszkowska R; Zakrzewski M; Maciorkowska E
    Dev Period Med; 2019 Oct; 23(3):159-162. PubMed ID: 33759428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting risk of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children.
    Rutstein RM
    Am J Dis Child; 1991 Aug; 145(8):922-4. PubMed ID: 1677526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole.
    Klinker H; Langmann P; Zilly M; Richter E
    J Clin Pharm Ther; 1998 Apr; 23(2):149-54. PubMed ID: 9786102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
    N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hypersensitivity cross-reaction with dapsone and cotrimoxazole in a patient infected by the human immunodeficiency virus].
    Jiménez-Lozano I; Alcalde M; Campany Herrero D; Monterde J
    Farm Hosp; 2013; 37(4):335-6. PubMed ID: 24010695
    [No Abstract]   [Full Text] [Related]  

  • 54. Adverse reactions to trimethoprim-sulfamethoxazole.
    Lee BL
    Clin Rev Allergy Immunol; 1996-1997 Winter; 14(4):451-5. PubMed ID: 9040971
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients.
    Mayer HB; Rose DN; Cohen S; Gurtman AC; Cheung TW; Szabo S
    AIDS; 1993 Dec; 7(12):1687-9. PubMed ID: 8286088
    [No Abstract]   [Full Text] [Related]  

  • 56. Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent.
    Rudy BJ; Rutstein R
    Pediatr Emerg Care; 1997 Jun; 13(3):216-7. PubMed ID: 9220510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TMP-SMX desensitization.
    Posit Aware; 1995; ():7. PubMed ID: 11362574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
    Smith CL; Brown I; Torraca BM
    Clin Infect Dis; 1997 Dec; 25(6):1477-8. PubMed ID: 9431404
    [No Abstract]   [Full Text] [Related]  

  • 60. Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus Infection.
    Siegel M; Masur H; Kovacs J
    Semin Respir Crit Care Med; 2016 Apr; 37(2):243-56. PubMed ID: 26974301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.